Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease

Journal of Autoimmunity

Volumn 14, Issue 1, 2000, Pages 99-105

  Powell, J J ^a   Harvey, R S J ^a   Ashwood, P ^a   Wolstencroft, R ^a   Gershwin, M E ^b   Thompson, R P H ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gastrointestinal tract; Inflammatory bowel disease; Interleukin 1; Titanium dioxide; Ultrafine particles

Indexed keywords

INTERLEUKIN 1; LIPOPOLYSACCHARIDE; TITANIUM DIOXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; DIET; DISEASE EXACERBATION; ENTERITIS; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL ABSORPTION; HUMAN; IMMUNOREACTIVITY; INGESTION; LYMPHOID TISSUE; MALE; MONONUCLEAR CELL; MUCOSAL IMMUNITY; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0033950621     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0342     Document Type: Article

References (29)

1. Duchmann R., Kaiser I., Hermann E., Mayet W., Ewe K., Meyer Zum Buschenfelde K.H. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102:1995;448-455.
2. Shepherd N.A., Crocker P.R., Smith A.P., Levison D.A. Exogenous pigment in Peyer's patches. Hum. Pathol. 18:1987;50-54.
3. Urbanski S.J., Arsenault A.L., Green F.H.Y., Haber G. Pigment resembling atmospheric dust in Peyer's patches. Modern Pathology. 2:1989;222-226.
4. Powell J.J., Ainley C.C., Harvey R.S.J., Mason I.M., Kendall M.D., Sankley E.A., Dhillon A.P., Thompson R.P.H. Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut. 38:1996;390-395.
5. Powell J.J., Thompson R.P.H. The chemistry of aluminium in the gastrointestinal lumen and its uptake and absorption. Proc. Nutr. Soc. 52:1993;241-253.
6. Ministry of Agriculture Fisheries and Food: Dietary intake of food additives in the UK: Initial surveillance, London, HMSO, 1993.
7. Gardiner K.R., Anderson N.H., McCaigue M.D., Erwin P.J., Halliday M.I., Rowlands B.J. Adsorbents as antiendotoxin agents in experimental colitis. Gut. 34:1993;51-55.
8. Lapre J.A., De Vries H.T., Van der Meer R. Dietary calcium phosphate inhibits cytotoxicity of fecal water. Am. J. Physiol. 261:1991;G907-G912.
9. Eastwood G., Trier J. Organ culture of human rectal mucosa. Gastroenterology. 64:1973;375-382.
10. Dionne S., D'Agata I.D., Hiscott J., Vanounou T., Seidman E.G. Colonic explant production of IL-1 and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD). Clin. Exp. Immunol. 112:1998;435-442.
11. Andus T., Daig R., Vogl D., Aschenbrenner E., Lock G., Hollerbach S., Kollinger M., Scholmerich J., Gross V. Imbalance of the interleukin 1 system in colonic mucosa-association with intestinal inflammation and interleukin 1 receptor agonist genotype 2. Gut. 41:1997;651-657.
12. 2. Biomaterials. 12:1991;593-596.
13. 3 U/ml of interleukin-2. J. Immunological Methods. 99:1987;7-11.
14. Hochella M.F. Surface chemistry, structure, and reactivity of hazardous mineral dust. Gutherie G.D., Mossman B.T. Health effects of mineral dusts. 1993;275-308 Bookcrafters Inc, Washington.
15. Kovacsovics-Bankowski M., Clark K., Benacerraf B., Rock K.L. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. U S A. 90:1993;4942-4946.
16. Harding C.V., Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153:1994;4925-4933.
17. Song R., Harding C.V. Roles of proteasomes, transporter for antigen presentation (TAP), and β2-microglobulin in the processing of bacterial or particulate antigens via an alternative class I MHC processing pathway. J. Immunol. 156:1996;4182-4190.
18. Babyatsky M.W., Rossiter G., Podolsky D.K. Expression of transforming growth factors α and β in colonic mucosa in inflammatory bowel disease. Gastroenterology. 110:1996;975-984.
19. Espevik T., Waage A., Faxvaag A., Shalaby M.R. Regulation of interleukin-2 and interleukin-6 production from T-cells: involvement of interleukin-1β and transforming growth factor-β Cellular Immunology. 126:1990;47-56.
20. Tucci A., James H., Chicheportiche R., Bonnefoy J-Y., Dayer J-M., Zubler R.H. Effects of eleven cytokines and of IL-1 and tumor necrosis factor inhibitors in a human B cell assay. Journal of Immunology. 148:1992;2778-2784.
21. Vidard L., Kovacsovics-Bankowski M., Kraeft S.K., Chen L.B., Benacerraf B., Rock K.L. Analysis of MHC class II presentation of particulate antigens by B lymphocytes. J. Immunol. 156:1996;2809-2818.
22. Lee J.C.W., Halpern S., Lowe D.G., Forbes A., Lennard-Jones J.E. Absence of skin sensitivity to oxides of aluminium, silicon, titanium or zirconium in patients with Crohn's disease. Gut. 39:1996;231-233.
23. Sharon P., Ligumsky M., Rachmilewitz D., Zor U. Role of prostaglandins in ulcerative colitis. Gastroenterology. 75:1978;638-640.
24. Ligumsky M., Simon P.L., Karmeli F., Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease - enhanced production during active disease. Gut. 31:1990;686-689.
25. Jones S.C., Haidar A., Hagan P. Cytokine production in the mucosa of patients with inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 5:1993;607-612.
26. Mahida Y.R., Lamming C.E.D., Gallagher A., Hawthorne A.B., Hawkey C.J. 5-Aminosalicylic acid is a potent inhibitor of interleukin 1β production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease. Gut. 32:1991;50-54.
27. Soderholm J.D., Olaison G., Lindberg E., Hannestad U., Vindels A., Tysk C., Jarnerot G., Sjodahl R. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence? Gut. 44:1999;96-100.
28. Nejdfors P., Wang Q., Ekelund M., Westrom B.R., Jansson O., Lindstrom C.L., Karlsson B., Jeppsson B. Increased colonic permeability in patients with ulcerative colitis: an in vitro study. Scand. J. Gastroenterol. 33:1988;739-753.
29. Churg A. The uptake of mineral particles by pulmonary epithelial cells. Am. J. Respir. Crit. Care Med. 154:1996;1124-1140.